Interleukin-10

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 16.06.2024

Dieser Artikel auf Deutsch

Synonym(s)

B-cell stimulatory factor (BSF); CSIF; Cytokine synthesis inhibiting factor; Cytokine synthesis inhibiting factor (CSIF); IL-10; IL-10B cell derived T cell growth factor (BTCGF)

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Interleukins (from Latin/Greek inter = between; leukos = white; kinein = to move) is the name given to a group of endogenous, short-chain regulatory proteins (cytokines) of the immune system (interleukin-1 to interleukin-35). Interleukins are mediators for induction, progression, and control of T-cell-mediated cytotoxic immune responses as well as B-cell activation (antibody production).

The gene encoding interleukin-10, as for interleukins-19 and -20, is located on chromosome 1q31-32.

Little is known about interleukin-10 receptors and the mechanism of signal transduction. IL10 is the defining cytokine of the "interleukin-10 family" with the homologous interleukins interleukin-19, -20 and interleukins -22, -24, -26.

The immunomodulatory interleukin-10 is secreted mainly by regulatory T cells (Treg). Furthermore, activated monocytes and mast cells secrete this cytokine.

General informationThis section has been translated automatically.

Interleukin-10 inhibits the effect of activated T cells and thus slows down the production of interferon-gamma. The cytokine acts (similar to interleukins-4, -11 and TGF-beta) as a so-called anti-inflammatory cytokine by inhibiting macrophage function and thus preventing excessive inflammatory reactions (interleukin-10 apparently exerts a protective function in the formation of atherosclerotic plaques). In TH1 cells, but not in TH2 cells, it inhibits cytokine synthesis, e.g. of interferon gamma, interleukin-2, TNF-beta and the chemokine CCL20.

Interleukin-10 thus inhibits the formation of cytokines of the Th1 response. In addition, interleukin-10 together with interleukin-2, interleukin-4 and interleukin-7 stimulates the growth of thymocytes and promotes the differentiation of cytotoxic T lymphocytes(CD8+T cells).

In addition, interleukin-10 promotes the differentiation of B lymphocytes and induces the secretion of immunoglobulins (IgG, IgA and IgM) in activated cells.

In macrophages, interleukin-10 inhibits the synthesis of interleukin-1, interleukin-6 and TNFalpha and inhibits antigen presentation. Effects In interaction with interleukin-3, interleukin-4 and peripheral lymphocytes, interleukin-10 stimulates the proliferation of mast cells. Various B-cell lymphomas also secrete interleukin-10.

There are numerous indications that interleukin-10 gene polymorphisms are associated with functional imbalances of the cytokine in various diseases. These include:

Interleukin-10 is particularly important for the immunology of the intestinal tract. Interleukin-10 deficiency is associated with a predisposition to chronic inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.

LiteratureThis section has been translated automatically.

  1. Cho MJ et al(2014) The dual nature of interleukin-10 in pemphigus vulgaris. Cytokines 73:335-341.
  2. Cho IH et al (2015) Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Hematology 20:121-128.
  3. Han X et al (2015) Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function.Thromb haemost 113:505-512.
  4. Kumar P et al (2016) Role of Interleukin-10 (-1082A/G) gene polymorphism with the risk of ischemic stroke: a meta-analysis. Neurol Res 38:823-830.
  5. Qiao YC et al (2016) Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. Clin Immunol 170:61-69.
  6. Trifunović J et al (2015) Pathologic patterns of interleukin 10 expression--a review. Biochem Med (Zagreb) 25:36-48.
  7. Yu Z et al (2013) The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS 17:200-214.
  8. Zhang Y et al(2015) Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis. Mol Genet Genomics. 290:2063-2073.

Authors

Last updated on: 16.06.2024